Skip to news
JQJO
Latest

Ozempic Shows Promise in Dementia Prevention | JQJO

Ozempic Shows Promise in Dementia Prevention

Ozempic Shows Promise in Dementia Prevention

Tap title to read story

0:00 / 0:36

A new study published in JAMA Neurology suggests GLP-1 drugs, like Ozempic and Wegovy, may lower dementia risk in type 2 diabetes patients. Researchers reviewed data from 23 trials involving 160,000 participants and found a statistically significant reduction in dementia or cognitive impairment specifically with GLP-1 receptor agonists. While the exact mechanism is unclear, this finding supports ongoing clinical trials investigating semaglutide's potential as a dementia preventative.

Published · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

Ocean's 14 Cast Reunion Challenges

Tap title to read story

0:00 / 0:00

Miley Cyrus Weds Maxx Morando

Tap title to read story

0:00 / 0:39

Trump Calls Putin a Friend

Tap title to read story

0:00 / 0:42

JQJO

Find your next story

Search JQJO’s current coverage.